Exodus Point Capital Management, LP Fortress Biotech, Inc. Transaction History

Exodus Point Capital Management, LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 19, 2022	SELL	$0.8 - $1.5 $23,186 - $43,474	-28,983 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$1.24 - $2.75 $20,135 - $44,654	16,238 Added 127.41%	28,983 $39,000
Q4 2021 Feb 11, 2022	BUY	$2.42 - $3.65 $1,118 - $1,686	462 Added 3.76%	12,745 $32,000
Q3 2021 Nov 15, 2021	BUY	$2.82 - $3.7 $282 - $370	100 Added 0.82%	12,283 $40,000
Q2 2021 Aug 16, 2021	BUY	$3.5 - $5.48 $42,640 - $66,762	12,183 New	12,183 $43,000
Q2 2020 Aug 14, 2020	SELL	$1.83 - $3.16 $42,639 - $73,628	-23,300 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$1.14 - $2.96 $70,003 - $181,764	-61,407 Reduced 72.49%	23,300 $44,000
Q4 2019 Feb 14, 2020	BUY	$1.25 - $2.57 $105,883 - $217,696	84,707 New	84,707 $218,000

862K

Ticker FBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,735,000
Market Cap $185M
Description
Fortress Biotech, Inc., a biopharmaceutical company, develops and commercializes pharmaceutical and biotechnology products. The company markets dermatology products, such as Ximino capsules to treat only inflammatory lesions of non-nodular moderate to severe acne vulgaris; Targadox for severe acne; Exelderm cream for ringworm and jock itch sympt...

Get notified when there are updates to the investment portfolio of Exodus Point Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Exodus Point Capital Management, LP with notifications on news.